You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Litigation for ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE


✉ Email this page to a colleague

« Back to Dashboard


US Court Litigation for ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Patent Trial and Appeal Board Cases for ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
6,417,191 Apotex Corp. ⤷  Sign Up 2014-06-02 06-02-2014 ViiV Healthcare Co. Inter partes review ⤷  Sign Up 12-08-2014 DAVID BARRY ⤷  Sign Up
6,417,191 Teva Pharmaceuticals USA, Inc. ⤷  Sign Up 2015-01-08 01-08-2015 ViiV Healthcare Co. Inter partes review ⤷  Sign Up 06-25-2015 DAVID BARRY ⤷  Sign Up
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.